Electroacupuncture at He-Mu points reduces P2X4 receptor expression in visceral hypersensitivity

Neural Regeneration Research

Volumn 8, Issue 22, 2013, Pages 2069-2077

  Guo, Xin Xin ^a   Chen, Ji Fei ^b   Lu, Yuan ^c   Wu, Lu Yi ^c   Weng, Zhi Jun ^c   Yang, Ling ^c   Xin, Yu Hu ^d   Lin, Xian Ming ^a   Liang, Yi ^a   Fang, Jian Qiao ^a  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^b ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^c Shanghai Key Laboratory of Traditional Chinese Clinical Medicine   (China)

^d FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Acupuncture; Combination of He Mu points; Electroacupuncture; Grants supported paper; Irritable bowel syndrome; Neural regeneration; Neuroregeneration; Traditional Chinese medicine; Visceral hypersensitivity

Indexed keywords

PINAVERIUM BROMIDE; PURINERGIC P2X4 RECEPTOR;

ABDOMINAL REFLEX; ABDOMINAL WITHDRAWAL REFLEX SCORE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROACUPUNCTURE; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IRRITABLE COLON; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEEDLE; NERVE STIMULATOR; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; VISCERAL HYPERSENSITIVITY; ACUPUNCTURE; COLON; SPINAL CORD; WITHDRAWAL REFLEX;

EID: 84886694774     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.22.006     Document Type: Article

References (67)

1. Saito YA, Schoenfeld P, Locke GR 3rd. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol. 2002;97(8):1910-1915.
2. Zhang SS, Li QG, Wei W, et al. Consensus on standard management of irritable bowel syndrome in TCM. Zhonghua Zhongyiyao Zazhi. 2010;25(7):1062-1065.
3. Kanazawa M, Hongo M, Fukudo S. Visceral hypersensi-tivity in irritable bowel syndrome. J Gastroenterol Hepatol. 2011;26 Suppl 3:119-121.
4. Keszthelyi D, Troost FJ, Masclee AA. Irritable bowel syn-drome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;303(2):G141-154.
5. Mathew P, Bhatia SJ. Pathogenesis and management of irritable bowel syndrome. Trop Gastroenterol. 2009;30(1): 19-25.
6. Kang MX, Jia H. Progress in mechanisms of visceral hypersensitivity in irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi. 2008;16(14):1554-1558.
7. Elsenbruch S. Abdominal pain in Irritable Bowel Syn-drome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun. 2011; 25(3):386-394.
8. Liu B, Hu YM, Tenner SM. A randomized controlled trial of acupuncture for irritable bowel syndrome. Am J Ga-stroenterol. 2000;95(9):2498.
9. Chan J, Carr I, Mayberry JF. The role of acupuncture in the treatment of irritable bowel syndrome: a pilot study. Hepatogastroenterology. 1997;44(17):1328-1330.
10. Xu GY, Shenoy M, Winston JH, et al. P2X recep-tor-mediated visceral hyperalgesia in a rat model of chronic visceral hypersensitivity. Gut. 2008;57(9):1230-1237.
11. Burnstock G. Purines and sensory nerves. Handb Exp Pharmacol. 2009;(194):333-392.
12. Burnstock G. Introductory overview of purinergic signalling. Front Biosci (Elite Ed). 2011;3:896-900.
13. Burnstock G. The past, present and future of purine nuc-leotides as signalling molecules. Neuropharmacology. 1997;36(9):1127-1139.
14. Burnstock G. Puncturing the Myth: purinergic signaling, not mystical energy, may explain how acupuncture works. Scientist. 2011-09-01.
15. Bleehen T, Keele CA. Observations on the algogenic actions of adenosine compounds on the human blister base preparation. Pain. 1977;3(4):367-377.
16. Zhang Q, Zhao Y, Guo Y, et al. Activation and sensitization of C and Adelta afferent fibers mediated by P2X receptors in rat dorsal skin. Brain Res. 2006;1102(1):78-85.
17. Vial C, Roberts JA, Evans RJ. Molecular properties of ATP-gated P2X receptor ion channels. Trends Pharmacol Sci. 2004;25(9):487-493.
18. Burnstock G. Acupuncture: a novel hypothesis for the involvement of purinergic signalling. Med Hypotheses. 2009;73(4):470-472.
19. Zhao ZQ. Neural mechanism underlying acupuncture analgesia. Prog Neurobiol. 2008;85(4):355-375.
20. Yu XJ, Ding GH, Yao W, et al. The role of collagen fiber in "Zusanli" (ST 36) in acupuncture analgesia in the rat. Zhongguo Zhen Jiu. 2008;28(3):207-213.
21. Qin M, Wang JJ, Duan L, et al. The changes of p2x4 receptor expression in nucleus of tractus solitarius and the dorsal horn of thoracic cord after visceral pain induced by acetic acid. Shenjing Jiepou Xue Zazhi. 2006;22(5):551-554.
22. Wang JJ, Wang SZ, Xia DY, et al. Effects of expressions of P2X4 receptor in nerve center induced by the stimula-tion of colorectal distention in rats with irritable bowel syndrome. Weichang Bing Xue yu Gan Bing Xue Zazhi. 2008;17(10):813-818.
23. Wang W, Bai L, Gao ZX, et al. Acupuncture at Tianshu, Shangjuxu point in diarrhea-predominant irritable bowel syndrome. Zhongguo Wuzhen Xue Zazhi. 2008;26(8): 6335-6336.
24. Zhang HS, Wang FC. Application of combination of he-mu points and combination of shu-yuan in syndrome differen-tiation of zang-and fu-organs. Zhongguo Zhen Jiu. 2006; 26(5):378-380.
25. Yang B, Yan XK. Nano-2D-LC analysis of proteomic altera-tions in rats with gastric stress ulcer after acupuncture at He-Sea point and Front-Mu point of the stomach meridian. Shijie Huaren Xiaohua Zazhi. 2012;18(22):2355-2358.
26. Gao ZX, Wang W, Lv EJ, et al. Influence of elec-tro-acupuncture on Shang-ju-xu on 5-HT and AWR in rats with visceralgia. Shanxi Zhongyi. 2010;26(4):53-55.
27. Zhou EH, Liu HR, Wu HG, et al. Suspended moxibustion relieves chronic visceral hyperalgesia via serotonin pathway in the colon. Neurosci Lett. 2009;451(2):144-147.
28. Liu HR, Wang XM, Zhou EH, et al. Acupuncture at both ST25 and ST37 improves the pain threshold of chronic visceral hypersensitivity rats. Neurochem Res. 2009; 34(11):1914-1918.
29. Zhou EH, Liu HR, Wu HG, et al. Herb-partition moxibus-tion relieves chronic visceral hyperalgesia and 5-HT con-centration in colon mucosa of rats. Neurol Res. 2009;31(7):734-737.
30. Wang XM, Liu HR, Ding GH, et al. Effects of electroacu-puncture on c-Fos expression in the spinal cord and brain of rats with chronic visceral hypersensitivity. Neural Regen Res. 2009;4(5):339-343.
31. Wu HG, Liu HR, Zhang ZA, et al. Electro-acupuncture relieves visceral sensitivity and decreases hypothalamic corticotropin-releasing hormone levels in a rat model of ir-ritable bowel syndrome. Neurosci Lett. 2009;465(3):235-237.
32. Wu HG, Jiang B, Zhou EH, et al. Regulatory mechanism of electroacupuncture in irritable bowel syndrome: prevent-ing MC activation and decreasing SP VIP secretion. Dig Dis Sci. 2008;53(6):1644-1651.
33. Yi T, Qi L, Wu HG, et al. Analgesic action of suspended moxibustion in rats with chronic visceral hyperalgesia correlates with enkephalins in the spinal cord. Neural Regen Res. 2012;7(3):219-222.
34. Ma XP, Tan LY, Yang Y, et al. Effect of electro-acupuncture on substance P, its receptor and corticotropin-releasing hormone in rats with irritable bowel syndrome. World J Gastroenterol. 2009;15(41):5211-5217.
35. Wu LY, Bao CH, Ge LB, et al. Mild moxibustion at Tianshu (ST 25) decreases expression of prokineticin-1 and pro-kineticin receptor-1 in colon tissue of rats with chronic visceral hyperalgesia. Neural Regen Res. 2011;6(33): 2600-2604.
36. Zhao C, Qi L, Wu LY, et al. Suspended moxibustion at Tianshu (ST25) inhibits prokineticin 1 and prokineticin receptor 1 expression in the spinal cord of rats with chronic visceral hypersensitivity. Neural Regen Res. 2012;7(15):1145-1150.
37. Liu HR, Qi L, Wang XL, et al. Electroacupuncture at Tianshu (ST 25) for diarrhea-predominant irritable bowel syndrome using positron emission tomography Changes in visceral sensation center. Neural Regen Res. 2010; 5(16):1220-1225.
38. Zhan LX, Li ZK, Zou LW, et al. Assessment of efficacy of pinaverium bromide in treatment of irritable bowel syn-drome and its effect on visceral motility and sensitivity. Zhonghua Xiaohua Zazhi. 2002;22(8):477-480.
39. Katsuragi T, Migita K. The mechanism of ATP release as an autocrine/paracrine molecule. Nihon Yakurigaku Zas-shi. 2004;123(6):382-388.
40. Burnstock G. The past, present and future of purine nuc-leotides as signalling molecules. Neuropharmacology. 1997;36(9):1127-1139.
41. Illes P, Ribeiro JA. Neuronal P2 receptors of the central nervous system. Curr Top Med Chem. 2004;4(8):831-838.
42. Burnstock G, Knight GE. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol. 2004;240:31-304.
43. Burnstock G, Wood JN. Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr Opin Neurobiol. 1996;6(4):526-532.
44. Hewinson J, Mackenzie AB. P2X(7) receptor-mediated reactive oxygen and nitrogen species formation: from re-ceptor to generators. Biochem Soc Trans. 2007;35(Pt 5): 1168-1170.
45. Tsuda M, Ueno S, Inoue K. Evidence for the involvement of spinal endogenous ATP and P2X receptors in nocicep-tive responses caused by formalin and capsaicin in mice. Br J Pharmacol. 1999;128(7):1497-1504.
46. Burnstock G. Purinergic P2 receptors as targets for novel analgesics. Pharmacol Ther. 2006;110(3):433-454.
47. Burnstock G. Purine-mediated signalling in pain and visceral perception. Trends Pharmacol Sci. 2001;22(4):182-188.
48. Wang W, Wu SX, Li YQ. Localization of P2X4 receptor in the rat nervous system. Jiepou Xue Jinzhan. 2001;7(4): 289-293.
49. Ma Y, Ning S, Lu N, et al. Expression of P2X2 and P2X4 receptors immunoreactivity in the medulla of neonatal and adult rats. Fudan Xuebao: Yixue Ban. 2006;33(5):666-670.
50. Cui Y, Chen Y, Zhi JL, et al. Activation of p38 mito-gen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance. Brain Res. 2006; 1069(1):235-243.
51. Zhou SQ, Yuan HB, Yan JQ, et al. Small-dose ketamine inhibit the expression of P2X4 receptor in cerebral cortex of the rats with chronic neuropathic pain. Linchuang Yixue Zazhi. 2009;37(4):548-551.
52. Wu HG, Zhou LB, Pan YY, et al. Study of the mechanisms of acupuncture and moxibustion treatment for ulcerative colitis rats in view of the gene expression of cytokines. World J Gastroenterol. 1999;5(6):515-517.
53. Wu HG, Liu HR, Tan LY, et al. Electroacupuncture and moxibustion promote neutrophil apoptosis and improve ulcerative colitis in rats. Dig Dis Sci. 2007;52(2):379-384.
54. Wu HG, Gong X, Yao LQ, et al. Mechanisms of acupunc-ture and moxibustion in regulation of epithelial cell apop-tosis in rat ulcerative colitis. World J Gastroenterol. 2004;10(5):682-688.
55. Wu HG, Zhou LB, Shi DR, et al. Morphological study on colonic pathology in ulcerative colitis treated by moxibus-tion. World J Gastroenterol. 2000;6(6):861-865.
56. Shi Y, Zhou EH, Wu HG, et al. Moxibustion treatment restoring the intestinal epithelium barrier in rats with Crohn's disease by down-regulating tumor necrosis factor alpha, tumor necrosis factor receptor 1, and tumor necro-sis factor receptor 2. Chin J Integr Med. 2011;17(3):212-217.
57. Bao CH, Wu LY, Wu HG, et al. Moxibustion inhibits apop-tosis and tumor necrosis factor-alpha/tumor necrosis fac-tor receptor 1 in the colonic epithelium of Crohn's disease model rats. Dig Dis Sci. 2012;57(9):2286-2295.
58. Bao CH, Wu LY, Shi Y, et al. Moxibustion down-regulates colonic epithelial cell apoptosis and repairs tight junctions in rats with Crohn's disease. World J Gastroenterol. 2011; 17(45):4960-4970.
59. Xiong JW. Clinical observation of acupuncture treatment on irritable bowel syndrome. Jiangsu Zhongyiyao. 2009; 41(1):49-50.
60. Ma TA, Xu Z. Treatment efficacy of Tiaoqi acupuncture on habitual constipation. Zhongyuan Yikan. 2005;32(16):29-30.
61. Wang SL. Treatment of acupuncture at Xiahe on chronic dysentery. Henan Zhongyi. 2005;25(6):63.
62. Liu HR, Wu HG, Wang XL, et al. Clinical research of irrit-able bowel syndrome treated by electroacupuncture on Tianshu (ST 25). Zhenjiu Tuina Zazhi. 2007;5(2):91-94.
63. Liu HR, Hua XG, Yang Y, et al. Expression of 5-HT in colonic mucosa of diarrhea-predominant IBS and the clinical efficacy of acupuncture treatment. Liaoning Zhongyi Zazhi. 2006;33(8):953-954.
64. Zhou EH, Wang XM, Ding GH, et al. Suspended mox-ibustion relieves chronic visceral hyperalgesia and de-creases hypothalamic corticotropin-releasing hormone levels. World J Gastroenterol. 2011;17(5):662-665.
65. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
66. Al-Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroen-terology. 2000;119(5):1276-1285.
67. Li ZR. Experimental Acupuncture. China Press of Tradition Chinese Medicine. 2007.